Co-Authors
This is a "connection" page, showing publications co-authored by Jérémie Guedj and Denis Malvy.
Connection Strength
0.489
-
Timing of Antiviral Treatment Initiation is Critical to Reduce SARS-CoV-2 Viral Load. CPT Pharmacometrics Syst Pharmacol. 2020 09; 9(9):509-514.
Score: 0.224
-
Dose Rationale for Favipiravir Use in Patients Infected With SARS-CoV-2. Clin Pharmacol Ther. 2020 08; 108(2):188.
Score: 0.221
-
Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targeted. PLoS Negl Trop Dis. 2017 02; 11(2):e0005389.
Score: 0.044